ANANTHAN SUBRAMANIAM has a total of 12 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are INVASC THERAPEUTICS INC, YAO WENQING and HENDRIX MARTIN.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Republic of Korea | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Ananthan Subramaniam | 12 |
#2 | Rothman Richard B | 10 |
#3 | Maddry Joseph A | 1 |
#4 | Grimaldi Maurizio | 1 |
#5 | Hobrath Judith Varady | 1 |
Publication | Filing date | Title |
---|---|---|
KR20170117023A | Heterocyclic compounds as biogenic amine transport modulators | |
KR20170117024A | Novel quinazolines as biogenic amine transport modulators | |
WO2011047129A1 | Treatment of neurodegenerative diseases, causation of memory enhancement, and assay for screening compounds for such |